Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - IDEXX LABORATORIES INC /DE | exhibit322.htm |
| EX-32.1 - EXHIBIT 32.1 - IDEXX LABORATORIES INC /DE | exhibit321.htm |
| EX-31.2 - EXHIBIT 31.2 - IDEXX LABORATORIES INC /DE | exhibit312.htm |
| EX-31.1 - EXHIBIT 31.1 - IDEXX LABORATORIES INC /DE | exhibit311.htm |
| EX-21 - EXHIBIT 21 - IDEXX LABORATORIES INC /DE | exhibit21.htm |
| EX-10.32 - EXHIBIT 10.32 - IDEXX LABORATORIES INC /DE | exhibit1032.htm |
| EX-10.28 - EXHIBIT 10.28 - IDEXX LABORATORIES INC /DE | exhibit1028.htm |
| EX-10.24 - EXHIBIT 10.24 - IDEXX LABORATORIES INC /DE | exhibit1024.htm |
| EX-10.22 - EXHIBIT 10.22 - IDEXX LABORATORIES INC /DE | exhibit1022.htm |
| EX-4.1 - EXHIBIT 4.1 - IDEXX LABORATORIES INC /DE | exhibit41.htm |
| 10-K - 10-K - IDEXX LABORATORIES INC /DE | idxx201910k.htm |
EXHIBIT 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-36007 and 333-70846) and Form S-8 (Nos. 333-11201, 333-11199, 333-36009, 333-56685, 333-78765, 333-78769, 333-43172, 333-43170, 333-27733, 333-105426, 333-108905, 333-108906, 333-146479, 333-160083, 333-160085, 333-193136 and 333-204418) of IDEXX Laboratories, Inc. of our report dated February 14, 2020 relating to the financial statements, financial statement schedule and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP | |
Boston, Massachusetts | |
February 14, 2020 | |